Our latest research report titled "Medical Courier Market Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis ? by Product Type, Destination, Service, and End User" indicates that the medical courier market was valued at approximately US$ 7,305.20 million in 2022. Projections suggest that this market will grow to around US$ 10,964.43 million by 2030, reflecting a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.
According to the International Diabetes Federation's 2021 report, diabetes affects 1 in 11 adults, translating to about 61 million individuals. The European region has the highest prevalence of type 1 diabetes among children and adolescents, with around 295,000 cases. The countries with the highest age-adjusted prevalence of diabetes among individuals aged 20 to 79 include Turkey, Spain, Andorra, Portugal, and Serbia.
A white paper published by Economist Impact, which was funded and initiated by AstraZeneca, reveals that chronic kidney disease (CKD) impacts approximately 1 in 10 adults in Europe. This means that around 100 million people in Europe are currently living with this progressive disease, and an additional 300 million individuals are projected to be at risk by 2023.
Prostate cancer (PCa) is the most prevalent non-skin cancer among men in Europe. Recent advancements in treatment are expected to lead to a decline in mortality rates associated with this disease within the European Union (EU). The incidence of PCa in Europe is notably higher than in regions like Africa or Asia, largely due to increased rates of prostate-specific antigen (PSA) screening, particularly in Eastern and Southern Europe. Biopsies, which involve extracting a small tissue sample from potentially cancerous areas, are crucial for accurate cancer detection.
Consequently, the rising incidence of chronic diseases such as diabetes, CKD, and cancer in Europe is driving the demand for medical supplies, thereby positively impacting the growth of the European medical courier market.
Major players in the medical courier industry are actively pursuing strategic initiatives, including partnerships, mergers, acquisitions, and collaborations, as well as launching new products to enhance their market presence. These efforts aim to facilitate quicker delivery of medical supplies, provide value-based care, and maintain a competitive advantage.
For example, in April 2023, UPS Healthcare inaugurated its first dedicated healthcare logistics facility in Giessen, Germany. This facility is designed to support the storage of various healthcare products at temperatures ranging from 2?C to 8?C, 15?C to 25?C, and down to -20?C. Throughout 2023, UPS Healthcare plans to expand its warehouse space by over 2 million square feet, with approximately half of this expansion occurring in Europe.
In September 2022, a consortium led by AGS Airports launched the next phase of the Care and Equity ? Healthcare Logistics UAS Scotland (CAELUS) project in collaboration with NHS Scotland. This initiative secured US$ 12.56 million in funding from the Future Flight Challenge at UK Research and Innovation in August 2022. CAELUS unites 16 partners, including NATS, University of Strathclyde, Atkins, and NHS Scotland, to establish a national drone network for transporting blood, essential medicines, and other medical supplies, particularly to remote communities in Scotland. The consortium previously secured US$ 1.86 million in January 2020 to design various drone landing stations for NHS sites and develop a virtual model of the delivery network connecting pathology labs, hospitals, distribution centers, and GP surgeries. The next phase will involve live flight trials and addressing remaining challenges to safely utilize drones at scale within Scotland's airspace.
Insights into the Medical Courier Market by Product Type
The medical courier market is categorized by product type into lab specimens, medical supplies and equipment, blood and organs, medical notes, and others. In 2022, the medical supplies and equipment segment accounted for the largest market share, while the lab specimens segment is expected to experience the highest CAGR during the forecast period.
Insights into the Medical Courier Market by Destination
In terms of destination, the medical courier market is divided into domestic and international segments. The domestic segment held the largest market share in 2022, while the international segment is projected to register the highest CAGR during the forecast period.
Insights into the Medical Courier Market by Service
The medical courier market is also segmented by service into standard services and rush/on-demand services. The standard services segment dominated the market in 2022, whereas rush and on-demand services are anticipated to achieve the highest CAGR during the forecast period.
Insights into the Medical Courier Market by End User
By end user, the medical courier market is segmented into hospitals and clinics, diagnostic labs, pharmaceutical and biotechnology companies, blood and tissue banks, in-home support, and others. The hospitals and clinics segment held the largest market share in 2022, while in-home support is expected to see the highest CAGR during the forecast period.
Key players in the medical courier market are pursuing growth through various strategies. For instance, in October 2022, Med Logistics Group Ltd partnered with Skyfarer and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust to conduct a trial for a Beyond Visual Line of Sight (BVLOS) drone in the UK. This innovative drone trial was conducted under a secure CAA-approved airspace known as "The Medical Logistics UK Corridor."
Several key primary and secondary sources, including the National Health Service, National Health Services Blood and Transplant, Essex Partnership University NHS Foundation Trust, British Medical Association, and the Department of Health and Social Care, were referenced in the preparation of the report on the medical courier market.